Atlas Trials

A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer

Clinical trial NCT00918008 · TERMINATED

Trial details

NCT number
NCT00918008
Sponsor
Memorial Sloan Kettering Cancer Center
Status
TERMINATED
Study type
OBSERVATIONAL
Bladder Cancer
Start date
2009-06-01
Primary completion
2011-05-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.